Literature DB >> 23048001

Tianeptine in combination with monoamine oxidase inhibitors for major depressive disorder.

Edward H Tobe1.   

Abstract

Major depressive disorder may respond to monotherapy with monoamine oxidase inhibitors (MAOIs) or tianeptine. Literature search showed no reports of MAOIs combined with tianeptine. The method included was clinical case history. A 59-year-old woman had partial improvement of depression with the MAOI tranylcypromine combined with topiramate, trazodone and ziprasidone. The patient had further improvement of depression symptoms after addition of tianeptine. No adverse events were evident. The combination of MAIOs and tianeptine may be effective for refractory major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23048001      PMCID: PMC4312778          DOI: 10.1136/bcr-2012-007044

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria.

Authors:  S Gabay; F M Achee; G Mentes
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

2.  Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system.

Authors:  Z Rogóz; G Skuza; D Dlaboga; J Maj; M Dziedzicka-Wasylewska
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

Review 3.  Neurochemical profile of tianeptine, a new antidepressant drug.

Authors:  G Kato; A F Weitsch
Journal:  Clin Neuropharmacol       Date:  1988       Impact factor: 1.592

4.  NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes.

Authors:  X Gao; X Xu; J Pang; C Zhang; J M Ding; X Peng; Y Liu; J M Cao
Journal:  Physiol Res       Date:  2006-08-22       Impact factor: 1.881

Review 5.  Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine.

Authors:  B S McEwen; J P Olié
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

Review 6.  Neurobiological and clinical effects of the antidepressant tianeptine.

Authors:  Siegfried Kasper; Bruce S McEwen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.